Sentinel lymph node biopsy status is not the most powerful predictor of prognosis in cutaneous melanoma.
Australas J Dermatol
; 58(4): 256-258, 2017 Nov.
Article
em En
| MEDLINE
| ID: mdl-29064087
Sentinel lymph node (SLN) status has been advocated in several recently published articles as the single most valuable prognostic marker for melanoma, and of greater prognostic importance than more established parameters such as Breslow thickness. A careful examination of the evidence for these claims, however, indicates that they are not substantiated by the available data, are somewhat misleading and suggest misinterpretation of the statistical analysis of the papers to which they refer. We will examine the basis for these claims and show why they are invalid.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Estatística como Assunto
/
Linfonodo Sentinela
/
Melanoma
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Australas J Dermatol
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Austrália
País de publicação:
Austrália